Kiora Pharmaceuticals (KPRX) Earnings Analysis

Kiora Pharmaceuticals (KPRX) next reports earnings on 2026-08-07, consensus EPS -0.47 USD. Last quarter (2026-05-08) it beat with EPS -0.58 USD vs -0.71 USD est (+18.3%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E -0.95.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does KPRX next report earnings?

Next earnings date2026-08-07
Consensus EPS estimate-0.47 USD
Revenue estimaten/a

KPRX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-08-0.58 USD-0.71 USD+18.3%Beat
2026-03-25-1.6 USD-0.67 USD-138.8%Miss
2025-11-070.01 USD-0.72 USD+101.4%Beat
2025-08-08-0.54 USD-0.58 USD+6.9%Beat
2025-05-09-0.52 USD-0.77 USD+32.5%Beat
2024-11-08-0.81 USD-0.9 USD+10%Beat
2024-08-09-0.53 USD-0.95 USD+44.2%Beat

Beat rate: 6/7 (86%) over reported quarters with consensus data.

KPRX valuation and analyst view

Trailing P/E-0.95
Trailing EPS-2.64927 USD
Price / book0.76
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Kiora Pharmaceuticals (KPRX)'s next earnings date?

Kiora Pharmaceuticals is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -0.47 USD.

Did KPRX beat earnings last quarter?

In its 2026-05-08 report, KPRX posted EPS of -0.58 USD versus a -0.71 USD estimate — a beat of 18.3%.

What is KPRX's earnings track record?

Over the last 7 reported quarters with consensus data, KPRX beat estimates 6 times (86%).

What is KPRX's current P/E ratio and EPS?

KPRX trades at a trailing P/E of -0.95 on trailing EPS of -2.649265282521183 USD.

What do analysts rate KPRX?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).